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Background: A number of single case reports have suggested that the context within which intervention studies
take place may challenge the assumptions that underpin randomised controlled trials (RCTs). However, the diverse
ways in which context may challenge the central tenets of the RCT, and the degree to which this information is
known to researchers or subsequently reported, has received much less attention. In this paper, we explore these
issues by focusing on seven RCTs of interventions varying in type and degree of complexity, and across diverse
contexts.
Methods: This in-depth multiple case study using interviews, focus groups and documentary analysis was
conducted in two phases. In phase one, a RCT of a nurse-led intervention provided a single exploratory case and
informed the design, sampling and data collection within the main study. Phase two consisted of a multiple
explanatory case study covering a spectrum of trials of different types of complex intervention. A total of eighty-
four data sources across the seven trials were accessed.
Results: We present consistent empirical evidence across all trials to indicate that four key elements of context
(personal, organisational, trial and problem context) are crucial to understanding how a complex intervention works
and to enable both assessments of internal validity and likely generalisability to other settings. The ways in which
context challenged trial operation was often complex, idiosyncratic, and subtle; often falling outside of current trial
reporting formats. However, information on such issues appeared to be available via first hand ‘insider accounts’ of
each trial suggesting that improved reporting on the role of context is possible.
Conclusions: Sufficient detail about context needs to be understood and reported in RCTs of complex
interventions, in order for the transferability of complex interventions to be assessed. Improved reporting formats
that require and encourage the clarification of both general and project-specific threats to the likely internal and
external validity need to be developed. In addition, a cultural change is required in which the open and honest
reporting of such issues is seen as an indicator of study strength and researcher integrity, rather than a symbol of a
poor quality study or investigator ability.
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The detailed reporting of both the operation and find-
ings of intervention-based studies is essential to inform
effective decision making and thus lead to real improve-
ments in healthcare provision. Decision makers, whether
at policy or practice level, need sufficient information in
both domains to answer four questions: What level of
benefit was achieved in the research? Are the findings
valid and reliable? Is the intervention sufficiently defined
as to allow it to be replicated? If replicated in other
places, would similar benefit still be achieved?
For ‘simple’ interventions such as pharmaceutical pro-
ducts (those which are easy to define, have few compo-
nents and for which the active ingredients are known)
researchers face relatively few problems in providing suf-
ficient information to help answer these questions. For
example, benefit can be defined in terms of confidence
intervals around primary and secondary outcome mea-
sures; reliability and validity can be assessed through ad-
herence to a pre-set list of methodological criteria; the
intervention can be defined in terms of dose and fre-
quency; and it is reasonable to assume that a similar
benefit will be obtained if replicated in a similar popula-
tion, irrespective of place.
However, policy makers and practitioners are increas-
ingly asked to make judgements regarding complex rather
than simple interventions; in these cases an array of new
problems arise. Complex interventions in healthcare are
built up from a number of components, which may act in-
dependently or interdependently although the ‘active in-
gredient’ is generally difficult to specify [1]. The
components usually include behaviours, characteristics of
behaviours (for example, frequency, timing), and methods
of organising and delivering those behaviours for example
type(s) of practitioners, setting and location.
In this paper, we describe potential problems identified
in the literature regarding the operation and reporting of
randomised controlled trials (RCTs) of complex inter-
ventions. While a number of case studies have shown
that the context within which intervention studies take
place may sometimes challenge the way in which inter-
ventions are delivered (particularly with regard to dose,
fidelity and reach) [2-4], the focus on a single trial has
necessarily limited their ability to identify the diverse
ways in which context may challenge the central
assumptions of the RCT, the degree to which these
occur consistently across different trial or intervention
types, or the degree to which this information is known
to researchers or subsequently reported.
The RCT and the challenge of the complex intervention
Randomised controlled trials and meta-analyses remain
the Gold Standard for evaluating the effectiveness of
interventions and informing guidelines, protocols andpolicies. The strength and usefulness of the RCT design
lies in its power to provide a credible link between cause
and effect. However, decision makers need to be able to
understand and define the cause. There is potential for
the cause to be the intervention itself, elements of the
healthcare context within which the intervention is
being delivered, elements of the research process that
are introduced to that setting (for example, presence of
researchers and their operations), or a combination of
all three. In other words, it is often difficult to separate
the intervention from the context within which it was
evaluated.
Common sense suggests, therefore, that RCTs of both
complex and simple interventions face these challenges,
as both take place in healthcare and experimental con-
texts which may adapt and evolve, be unpredictable, and
involve the interconnected actions of individuals [5].
However, for simple interventions these may pose fewer
problems as the intervention is easier to define, easier to
separate from context, and those contextual influences
that may have the potential to influence the results are
easier to separate and standardise [6]. The more
nuanced relationship between complex interventions
and the healthcare and experimental contexts in which
they are situated, poses a greater number of important
challenges.
First, the components of a complex intervention may
be difficult to define precisely as the distinction between
intervention and context is unclear. The rigour that is at
the heart of the scientific method embodied in the RCT
requires a hypothesis, which includes an a priori defin-
ition of the intervention (that is, that A will/will not lead
to B). However, given that complex interventions may
consist of a mix of people, skills, devices, contexts, pro-
cesses, actions and decisions, developing a definition of
‘A’ is always likely to be problematic, and this has been
recognised by the UK’s Medical Research Council
(MRC) in their framework for the development and
evaluation of complex interventions [7]. In practice, a
single approach to definition may not be possible. In-
deed, authors have pointed out that complex interven-
tions require flexibility in their definitions, so that
instead of defining and standardising them by ‘form’,
they should be defined by ‘function’ [8], with clear indi-
cation of whether components are ‘fixed’ or ‘flexible’ [9].
Second, even where interventions can be defined and
separated conceptually from their healthcare contexts,
those elements of context that might influence trial op-
eration or outcome may not be straightforward to iden-
tify and may be almost impossible to control or
standardise. Indeed some settings may themselves be
characterised as complex systems: being multifaceted,
experiencing constantly shifting contexts and more simi-
lar to a dynamic ecology [10]. The greater the
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which an intervention definition blurs into or depends
on elements of context for its effectiveness. If the con-
text cannot be fully controlled, then standardisation of a
blurred intervention becomes impossible [11].
Third, since defining the intervention and controlling
the clinical and experimental context is problematic, it
may be difficult to know post facto what precisely led to
any change detected in the RCT. Consequently, there is
likely to be insufficient information to allow practi-
tioners to make meaningful decisions about whether and
how to implement it in their own setting to maximise ef-
fectiveness [12-15]. Even pragmatic trials do not fully get
around these problems - although they provide more in-
formation about real world settings, their heterogeneity
may limit the usefulness of their results for specific clin-
ical situations [16,17], and the debate continues as to the
merits and pitfalls of explanatory versus pragmatic trials
[18]. Understanding the particular contexts in which
interventions are evaluated is important for any clinical
decision maker, regardless of where the trial sits on the
explanatory-pragmatic continuum, as ‘any attempts to
extrapolate from study settings to the real world are
hampered by a lack of understanding of the key ele-
ments of individuals and the settings in which they were
trialed’ (ICEBeRG, p5) [19].
If the relationship between intervention and context
cannot be fully controlled then it should at least be fully
acknowledged and its likely impact reported. This would
assist in the interpretation of the results of RCTs [20],
the implementation of research [21], and the synthesis
of evidence from RCTs of complex interventions [22]. In
practice, many studies lack basic information about the
trial and clinical contexts [15]. This is perhaps unsur-
prising, as guidelines for reporting trials, have not, until
recently, emphasised the importance of details about
intervention components, standardisation and adherence
[23,24]. Indeed, these guidelines omit some aspects of
interventions that may be important to understanding
links between treatment and outcomes, including cul-
tural sensitivity, adaptability and strategies for treatment
implementation [25]. Given that inadequate reporting of
these issues can undermine judgements about the qual-
ity and generalisability of trials, it is important to explore
ways in which reporting can be improved and a common
language developed.
Although retrospective data collection about trial im-
plementation may be helpful (particularly in detecting
unanticipated issues), a more rigorous approach would
be to know a priori those issues that are likely to
threaten the internal validity of the trial and those that
may impede the effectiveness of the intervention. Previ-
ous research has explored aspects of the context to: de-
sign a trial [26]; pilot or understand an intervention [27];and explain process or interpret the findings of their re-
search [28]. However, the issues and problems identified
by this research have not been explored across a
spectrum of different trial situations and we therefore do
not know whether they are generalisable to other trials
of complex interventions.
Consequently, this paper reports a study that moves
beyond previous single case studies of complex interven-
tions, and uses a multiple case study approach to ex-
plore these diverse issues. Further details of the study
including extensive description of methods and wider
findings are available elsewhere [29]. In particular, this
study seeks to:
 explore, from the perspectives of researchers and
practitioners, what goes on ‘behind the scenes’ in
randomised trials of complex interventions and
establish what information on potential threats to
trials is available and known to those running them;
 set out the particular challenges of achieving control
and standardisation in a real life setting, and;
 describe key elements of trial environment and
indicate how this might affect the implementation of
complex interventions.
Methods
A multiple case study approach was chosen as it expli-
citly acknowledges the importance of context [30] and is
known to be particularly useful for answering ‘how’ or
‘why’ questions through the detailed examination of
complex phenomena [31]. The distinct features of the
case study approach are the use of multiple sources of
evidence and the development and testing of theoretical
propositions. Case studies can be exploratory (focusing
more inductively on developing theory and theoretical
propositions), explanatory (focusing on the more
detailed examination and testing of propositions), or a
combination of both [32].
The study was conducted in two phases. Phase one
informed the design, sampling and data collection within
the main study (Table 1). In particular, it attempted to
identify potential variables of complexity and establish
theoretical propositions that could be investigated and
tested in phase two’s trials (Table 2). Phase two consisted
of a multiple explanatory case study covering a spectrum
of trials of different types of complex intervention. The
study was approved by the Tayside Medical Research
Ethics Committee, reference number 05/S1401/1.
Sampling
The case in phase one (RCT of a nurse-led model of
early discharge following axillary clearance surgery for
breast cancer - the NLED trial) was selected for conveni-
ence, with MW being the principal investigator (PI) of
Table 1 Description of intervention in single exploratory case study
Abbreviated
name for trial
Aim of trial Setting and wider context Nature of intervention Nature of control
intervention(s)
Phase 1: Single exploratory case
Aim: To identify potential variables of complexity for and to establish theoretical propositions that could be tested in phase 2
NLED To evaluate the impact of a
specialist nurse-led model of
early discharge following
breast cancer surgery on
patients, carers and the
health service, whilst
developing collaborative care
pathways that enable a smooth
transition between acute and
primary care
NHS teaching hospital/cancer
centre on two sites (one large
university hospital, one smaller
district general hospital), with a
large geographical catchment
area encompassing urban, rural,
affluent and deprived communities
in North East/ Central Scotland
Nurse-led early discharge - going
home with wound drains still in situ,
one or two days after surgery, with a
package of care in place. This group
was allocated to one of two nurses
from the breast care team who
received training from clinical nurse
specialists
Usual care - staying in
hospital post-operatively
until all wound drains
were removed
(approximately five
or six days)
NHS, National Health Service.
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the intention of using it as a future case, prospective
data had been collected by the PI on the conduct and
experiences of the trial staff throughout the course of
the trial. For phase two, the National Research Register
(NRR) [34] was used to locate a further seven trials of
complex interventions representing differing characteris-
tics of complexity identified in phase 1 (see Table 3).
Trials varied from an information leaflet for parents of
children with benign febrile convulsions to a supportive
intervention for carers of people with schizophrenia
(Table 2). The decision to sample seven trials was prag-
matic, and as the selection was based on the complexity
spectrum (Table 3), consistent with theoretical sampling
of cases as described by Yin [30].
Recruitment
In phase one, the nurses most closely involved in the
NLED trial were asked to participate in in-depth inter-
views at various times throughout the trial. In phase
two, principal investigators (PIs) were contacted by
email or telephone and then sent an information letter if
they were interested in participating. All agreed to take
part in a one-off interview, and gave permission for re-
search documents to be accessed via the Research and
Development Office. Six out of seven trials had recently
finished recruiting. For the trial that was still underway,
both the PI and research assistant were interviewed.
Data collection
A total of eighty-four key data sources were used across
the two phases. Table 4 provides a summary of data
types collected. These included in-depth interviews,
focus groups and trial documentation. In phase one, four
nurses responsible for delivering the intervention were
interviewed prospectively on several occasions during
the RCT. Two additional interviews were conducted
with the research nurse who was responsible for data
collection and the ward manager who was closelyinvolved with the patients who participated in the trial.
In phase two, a total of seven principal investigators
(PIs) and one research assistant were interviewed. A fur-
ther three focus groups were conducted, one with three
research nurses, another with two nurse members of an
ethics committee, and one with four PIs. Thus, four PIs
took part in a focus group and were interviewed, while
other participants were either interviewed or partici-
pated in focus groups.
In-depth interviews were conducted with PIs and
researchers in their workplaces. The topic guide included
questions related to their experience of coordinating the
trial; their views of how the intervention had developed
and was implemented; and the way in which participants
and practitioners responded to the trial. Interviews lasted
between 60 and 90 minutes. Multiple trial documents
such as proposals, ethics submissions, monitoring and
final reports, and publications were also examined, provid-
ing a more ‘public’ account of each trial.
Analysis
The transcripts were analysed using the ‘framework’ ap-
proach frequently employed in applied qualitative research
[35]. It involved several stages. The first five transcripts
were read and initial categories were identified (called fa-
miliarisation). These were then compared with concepts
in trial documents and the literature. The trial documents
provided a means of triangulating the personal accounts
of researchers with a more objective record of events. An
initial thematic framework was developed and applied to
transcripts not involved in the familiarisation process. The
framework was then systematically applied to the data sets
using a qualitative software analysis package (NVIVO 2)
[36]. The analysis was developed further by the creation of
charts which cross-linked categories and concepts to gen-
erate new meanings. Finally, the original research ques-
tions were reconsidered and examined to define concepts,
map the range and nature of phenomena, create typolo-
gies, find any associations and provide explanations.
Table 2 Description of interventions in phase 2
Abbreviated
name for trial
Aim of trial Setting and wider context Nature of intervention Nature of control
intervention(s)
Phase 2: Multiple explanatory case study
Aim: To seek empirical support for the theoretical propositions and assess likely validity across multiple trial types and contexts
Trial 1:
Waiting list
To determine whether patients
and their partners who receive
an extended home-based
programme of pre-cardiac
surgery education and support
demonstrate equal or greater
benefit compared with those
who receive a short hospital-
based programme
NHS Health Board
covering a large geographical
area with no cardiac surgery.
Contract with a neighbouring
Health Board for cardiac surgery.
Mixed urban/rural, affluent/
deprived population, with a
range of GP practices
(single-handed to group practices)
Education and support
intervention for patients on
waiting list for coronary artery
bypass surgery, delivered over
six months with alternate
monthly home and practice
nurse visits
One-off three-hour
education and support
class delivered in hospital
setting for patients in the
same target group, soon
after joining the waiting
list
Trial 2:
Information
To evaluate the benefits of a
new information leaflet given
to parents/guardians when their
child is discharged from hospital
following a benign febrile
convulsion
Paediatric unit in large
teaching hospital in Scotland
An information leaflet for
parents of children with
benign febrile convulsions,
designed to meet current
standards of written
information
An information leaflet for
the same target group,
not designed to meet
current standards of
written information
Trial 3:
Exercise
To determine the acceptability
and effects of an aerobic exercise
intervention during radiotherapy
for localised prostate cancer
on fatigue
Cancer centre in Scotland Exercise intervention to
reduce fatigue in patients
undergoing four weeks
of radiotherapy for prostate
cancer. One to one session
with physiotherapist for
tailored exercise instruction
A weekly phone call with
a clinical nurse specialist.
No specific exercise
guidance
Trial 4:
CBT
To assess the relative
efficacy in routine
practiceof clinical nurse
specialists providing
cognitive-behaviour
therapy for psychotic
patients suffering from
chronic, distressing
symptoms only partially
relieved by medication
Hospital and
community psychiatric
services in a large
Health Board in
Scotland
Twenty sessions
of cognitive behavioural
therapy, delivered over nine
months, for patients with
medication-resistant
psychotic symptoms
Two controls:
1) usual psychiatric care
2) twenty supportive
psychotherapy sessions
Trial 5:
Guidelines
To determine the
effectiveness of a national
guideline in improving quality
of life in epilepsy sufferers. To
evaluate the effectiveness of
two different implementation
strategies for this guideline
General practices in a
large Health Board area
in Scotland
Interactive workshops,
structured record sheets
and specialist nurse
facilitation to improve the
management of epilepsy
through clinical guidelines
Two controls:
1) guideline only sent
to GP practices
2) interactive workshops
and structured record
sheets but no specialist
nurse input
Trial 6:
Sleep
To examine the impact of
disorders of initiating and
maintaining sleep on mothers’
mental health. To evaluate the
cost effectiveness of a tailored
sleep programme, provided by
health visitors, in improving the
mother’s mental health and the
child’s sleep disorder
Fifteen GP practices within a
large Health Board area
in Scotland parents for
children’s sleep
Tailored behavioural
intervention programme
delivered to disorders by a
health visitor over six weekly
sessions
Two controls:
1) information
booklet only
2) waiting list for
programme
Carers To evaluate the effectiveness
of a community mental health
nurse (CMHN)-led intervention
in supporting carers who look
after a person who is diagnosed
with schizophrenia. The intervention
was compared with support that
is normally offered to carers by
CMHNs
Two Health Board areas in
Scotland. Recruitment also took
place through local carer
support groups
Supportive intervention to
meet the needs of carers
of people with schizophrenia,
delivered at home over twelve
weeks by nurses trained to
provide a carer-focused
intervention
Supportive intervention
to same target group,
delivered over twelve
weeks by nurses not
trained to provide a
carer-focused intervention
CMHN, community mental health nurse; GP, general practitioner; NHS, National Health Service.
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Table 3 The complexity spectrum
Characteristic Simple Highly complex
1. Number of components
within intervention
One
for example, single drug
Several
for example, rehabilitation package
2. ‘Dose’ or intensity of
intervention
Pre-determined/uniform
for example, specified dose drug or
pre-prepared information leaflet
Dependent on characteristics or
participation of individual
for example, exercise intervention
3. Clarity re the components
of the intervention
Clearly defined components
delivered in a specified order
for example, diagnostic procedure
Less well-defined components not
delivered in a particular order
for example, behavioural intervention
4. Degree of confidence in
the ‘active ingredient’
Known ‘active ingredient’
for example, specific medication
Unknown active ingredient even
if components are known
for example, smoking cessation activity
5. Timing of intervention Single event
for example, one-off procedure
Protracted intervention or
multiple time points
for example, follow-up care
6. Number of people
involved in delivery
One Several
7. Clarity of responsibility
in intervention
Clearly defined Ill-defined
8. Number of professional
groups involved
One Several
9. Technical or professional
skill involved
Minimal skill
for example, sending
information by post
Highly skilled
for example, surgical procedure
10. Human interaction
required to deliver the
intervention
Little
for example, dispensing
of a medication
Intervention is dependent
on human interaction
for example, counselling
11. Setting Single well-defined setting
for example, single therapy room
Cross boundary or multiple settings
for example, hospital at home scheme
12. Level of patient
involvement or active
participation
Low
for example, radiotherapy
treatment
High
for example, self-care
intervention or group activity
13. Sphere of impact Narrow
for example, influences individual
patients but no impact on or
involvement of rest of service
Broad
for example, service development
intervention with
implications for entire service
14. Clarity of main outcome Clear and obvious outcome
for example, cessation of smoking,
length of stay following
early discharge
Ambiguous outcome(s)
for example, improvement in
quality of life or patient
satisfaction, multiple outcomes
that are all important
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that is, until the additional data did not add to the devel-
oping theory.
Data were analysed as they were collected to ensure that
the consultation process was comprehensive. Thus, im-
portant issues raised in earlier interviews were fed into
subsequent ones, enabling emerging conceptual ideas to
be explored in further questioning. Several strategies were
also employed to improve the accuracy and validity of the
data. Regular meetings between the PI and a senior re-
searcher (BW) were held to check the interpretation of
key texts, codes and categories, and new lines of inquiry.Rigour was ensured in the coding process through the in-
volvement of a second coder (JT). Part-way through the
analysis, the second coder assigned established codes to
ten transcripts and compared these with those of the first.
Where differences were identified, these were discussed
and further refinement of the meaning of specific codes
was established to aid consistency, rigour and credibility
of the codes [37,38] in the ongoing analysis. The team also
searched for disconfirming evidence for developing theory
to ensure transcripts were not analysed selectively.
In phase two, interviews, documents and trial docu-
mentation were searched to test and further develop the
Table 4 Summary of data collection
Number and nature of
participants/documents
Total number of data
sources (interviews,
focus groups and
documents)
Phase 1: Single exploratory case
Interviews Thirteen longitudinal interviews
with four breast care nurses:
15
Three interviewed three times.
One interviewed four times.
Plus: one interview with a
research nurse
And one interview with a
charge nurse
Documents Protocol, ethics application,
monitoring reports x 2, final
report, Minutes of meetings x
15, field notes of PI and
researcher
22
Phase 2: Multiple explanatory case study
Interviews Seven principal investigators
and one research assistant
8
Documents Seven trial protocols/proposals 30
Six ethics forms
Five monitoring reports
Seven final reports
Five published papers
Focus One group with three research
nurses
9
groups One group with two nurse
members of the ethics
committee
One group with four PIs
Total 84
PI, principal investigator.
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took place in three stages. First, MW examined all docu-
mentation to identify detailed events and conceptual
sub-domains that contributed to each main theoretical
proposition. Second, BW and MW then re-examined all
documents and independently identified whether or not
there was empirical support for each sub-domain in each
individual trial/case; where there was disagreement, this
was resolved through discussion. Third, the strength and
plausibility of support from the data for each proposition
and sub-domain was ranked as absent, suggestive sup-
port, or clear support. All ranking was agreed by BW
and MW.
Results
Phase 1: the exploratory case
Interviews with those involved in the NLED trial
revealed that challenges to standardisation of theintervention took place in a dynamic context. The atti-
tudes and behaviour of the nurses changed over the
course of the trial, as did organisational factors and re-
search staff, all of which influenced how the intervention
was delivered. Three key issues were identified.
1. Changing attitudes towards the intervention among
practitioners, participants, and researchers. Changes
in skills and confidence of practitioners.
2. The influence of trial participants (patients and
family members) on practitioner delivery of and
engagement with the intervention.
3. Changes in organisational context, including team
members, relationships between staff, and the
priorities of the practice setting. Thus, interventions
can become more or less of a priority in comparison
with other events going on within the healthcare
context.
Issues identified in phase one - the exploratory case:
1. Changing attitudes towards the intervention.
Nurses adapted the intervention to meet individual pa-
tient needs as they became more familiar with the trial
and more confident in terms of the intervention and
were less likely to strictly follow the protocol when
implementing the intervention. Thus the timing of some
aspects of the intervention and the use of standardised
assessment forms varied.
‘At the beginning . . . we were new to this and we
wanted to make sure we did it all perfectly. I think
now we’ve become more relaxed . . . and realise
although we’re doing the study they’re still individual
patients and what’s right for them.’ Nurse 1, fourth
interview.
This led to patients receiving different combinations of
intervention components such as extra phone calls or
visits. The way the intervention was delivered was
dependent on the individual nurse:
‘When you are looking at a small team, it’s very much
about the people who are delivering it . . . a lot of the
time I think it’s more related to the nurses’ needs, or
time . . . I don’t think we do standardise the
intervention to be honest, it’s really up to the
individual nurse as to what they put into that patient
and it’s obvious that some people get more than
others.’ Nurse 4, fourth interview.
Nurses’ increased familiarity with the intervention also
encouraged them to suggest modifications to the pack-
age. For example, some nurses felt the specialist breast
care (intervention) should shift from the first few days
after surgery to several weeks later, when the emotional
impact of surgery had ‘sunk in’. This did not happen as
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how nurses providing the intervention developed their
own ideas and preferences, and that these changed.2. The influence of trial participants.
Patients and carers can also influence what happens
within an intervention, for example by interrupting, ask-
ing questions, changing the subject or simply just being
there:
‘I think there’s probably been women that I’ve been to
see that when I think about it now that would’ve
probably opened up a bit more but didn’t have the
opportunity to because someone was around, the
carer was around.’ Nurse 2, third interview.
Patients might also prioritise certain aspects of the inter-
vention above others, and thus influence which compo-
nents were delivered. One nurse complained of her
patients only wanting to talk about their wound drains.
‘I mean their main concern is the drain . . . they are
desperate to tell me about the drain, you need to say
right, ok then, so the drain is fine . . . let’s talk about
how everything else has been.’ Nurse 3, first interview.
Other patients stressed what they felt were critical
aspects of intervention, so that the information they gave
would be used to benefit of other patients in the future.
‘Because she knew she was in the study, she kept
saying “I’ll just tell you because it might help
somebody else”, she has always got this list, list of
things she wanted to tell me because it might help
somebody else.’ Nurse 1, first interview.3. Changes in organisational context.
The demands of the organisation, and the perceptions
and needs of other staff affected the delivery of the inter-
vention. Minutes of study progress meetings show that the
time spent on the intervention depended on practicalities
such as travelling to patients’ homes. In severe weather,
the breast care nurses gave responsibility for most of the
intervention to district nurses who were able to visit
patients more easily. However, breast care nurses noticed
when they visited together, the district nurses would steer
the intervention towards areas unrelated to the interven-
tion. Staff changes during the trial impinged on the way in
which the intervention was delivered. Two designated
breast care nurses left their posts after the first year of the
study and the workload was passed to the two senior
nurses, who had other responsibilities. Minutes of meet-
ings record that the senior nurses found the intervention
increasingly burdensome and the research nurse describes
how their enthusiasm for the intervention waned:
‘The difficulty is because they have lost one member
of staff, it is only the two of them and they work fivedays a week as it is and they must just think they
don’t want to do it . . . and I can sympathise.’ Nurse 4,
fourth interview.
Progress reports and meeting minutes repeatedly high-
lighted organisational factors, which altered the context
in which the intervention was delivered and may have
introduced new variables. One was the opening of a new
five-day ward approximately six months into the trial.
This meant that patients in the intervention group were
often admitted to the five-day ward, rather than to the
original breast surgery ward, to which the control group
were admitted. A shortage of anaesthetists also led to
numerous cancelled operating lists, which caused organ-
isational difficulties for the implementation of the trial
because patients were not admitted as planned.
It was clear from participants’ perspectives that
complexity-related threats to internal and external validity
existed within and between three key contexts: personal
(attitudes and behaviours of staff, patients and family
members), organisational (local service delivery structures
including organisational and professional roles and re-
sponsibilities), and trial (the implementation of the meth-
ods of the trial itself on top of the organisation of ‘usual
care’). Given this tripartite classification, it became clear
that issues could be broken down further to produce a
broader list of variables that might define the varying scale
and nature of complexity of an intervention and its con-
text. This ‘complexity spectrum’ is shown in Table 3.
Three broad theoretical propositions were generated
from the findings of phase one, which appeared to hold
for the single exploratory case and could be then tested
against a spectrum of further studies of interventions
varying in scale and type of complexity.
Proposition 1:
The context within which complex interventions take
place is crucial to understanding how the particular
complex intervention works and whether it will be
generalisable to other settings.
Proposition 2:
Complex interventions evolve during the process of a
trial. Perceptions, roles and practices change over time
and have a bearing on the delivery of the intervention.
Proposition 3:
If complex interventions comprise of different
dimensions, are influenced by the people and context,
and evolve and change during a trial, then some of the
fundamental assumptions of RCTs may be
compromised.
Phase 2 - testing the theoretical propositions
The seven trials included in phase two provided support
for each main proposition coming from phase 1. In
Table 5 Support for proposition 1 - the context within
which complex interventions occur is crucial to
understanding how that intervention works and how it
might be generalisable
Findings in support of proposition Evidence source
Trial
1
Trial
2
Trial
3
Trial
4
Trial
5
Trial
6
Trial
7
1. Complex interventions (to a greater
extent than simple interventions) may
require or result in changes in care
delivery and therefore demand the
involvement and commitment of
practitioners and participants within
practice settings to make them
happen.
✓✓ ✓ ✓ ✓ ✓✓ ✓✓ ✓✓
2. Complex interventions are shaped
or co-constructed by aspects of
context. Indeed, it seems that the
context of a complex intervention
may in fact be considered to be a
part of that intervention.
✓✓ ✓✓ ✓ ✓✓ ✓✓ ✓
3. The problem context encompasses:
• The nature and stability of the scale,
distribution and causal mechanism of
the problem that the intervention is
designed to address. These can
change over time and in relation to
changes in personal and organisational
contexts.
✓✓ ✓✓ ✓✓ ✓✓ ✓✓
4. The personal context encompasses:
• Factors related to the practitioners
involved - perceptions of relevance
and interest in the intervention, skills,
motivation, beliefs, preferences, affinity
for intervention, ability to fit it in.
✓✓ ✓ ✓✓ ✓✓ ✓✓ ✓ ✓✓
• Relationships between the
practitioner and the participant may
become sufficiently important that it
becomes a mechanism of action that
may facilitate or hinder the
effectiveness of the intervention.
✓✓ ✓ ✓✓ ✓✓ ✓✓ ✓
5. The organisational context
encompasses:
• Organisation of services, managerial
support, practicality of delivering
interventions, staff availability, venue
and timing.
✓✓ ✓✓ ✓✓ ✓ ✓✓
6. The trial context encompasses:
• Personal and interpersonal factors
related to the researcher(s) - beliefs
and preferences, commitment, role in
trial, relationships with practitioners
and participants, background and
allegiances.
✓✓ ✓✓ ✓✓ ✓✓ ✓✓ ✓✓ ✓✓
• Real and perceived knock-on effects
of the intervention on the practice
setting.
✓ ✓ ✓✓ ✓✓ ✓ ✓✓
✓ = some evidence (one instance); ✓✓ = strong evidence (more than one
instance); no check/tick = no specific evidence.
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of sub-domains related to each proposition.
Support for proposition 1 - the importance of context in
understanding the mechanism and generalisability of com-
plex interventions - was highly evident and spread evenly
across all trials (see Table 5). Clearest and most consistent
support was identified in relation to the impact of trial con-
text. However, cross-comparison of the studies generated a
reconceptualisation of context as consisting of four, rather
than the original three, key contextual domains identified in
the original exploratory case. In addition to personal, organ-
isational and trial contexts, it was clear that development of
the intervention and operationalisation of it in practice
depended on a conceptualisation of the nature, scale, and
cause (including stability of the cause) of the underlying
problem that the intervention was designed to address. This
was therefore referred to as the ‘problem context’.
There was evidence from a number of trials that the
problem context was not only crucial to the success of
the intervention but also the utility of the trial results,
and thus generalisability. In each study there had been a
generally implicit assumption of the cause or nature of
the problem, which had then informed the solution - the
intervention. However, throughout some of the trials the
nature, scale and cause of the problem appeared to shift
(with varying and sometimes unknown impact on its size
and frequency). For example, in one trial, the interven-
tion was designed for implementation during the phase
in which patients were on the waiting list for cardiac by-
pass surgery. However, during the trial, waiting list tar-
gets and fast track initiatives were introduced through
policy change, and this meant that the opportunity to
deliver the intervention was shortened for many partici-
pants. As the researcher explained,
‘. . . that was really what crucified the trial because
people just didn’t get the interventions they were
supposed to get, and I couldn’t recruit certain people,
you know, so the whole trial just changed. The
outcome of it changed completely, because I couldn’t
do the analysis that was originally planned.’
In examining the evidence further it became apparent
that a major cause of the instability of the problem con-
text lay in two further factors: the interdependence of
the problem, personal, organisational, and trial contexts,
and their own susceptibility to change over time. Conse-
quently, a change in a single factor in one contextual do-
main had implications for other contextual domains. An
example of this ‘ripple effect’ was evident in several trials
[29] (see Table 6, finding 4).
The PI of the carers’ trial described an already existing
climate of dissatisfaction amongst carers of people with
schizophrenia towards the service provided. Service
reorganisation and managerial change took place during
the trial, resulting in further dissatisfaction as well as
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practitioners who were asked to recruit carers.
‘They [staff] really kept contacting us saying please we
want to take part but they were told they couldn’t . . .
they moved geographical area and there was
redistribution of staff, some staff left, new staff came in.
It caused all sorts of issues and it delayed the period for
recruitment and it also delayed the period for the
intervention . . . some of these contextual things are not
planned for, they happen during the study . . . One
service was threatened with closure and carers were
furious because it meant they would have to travel.
They were so angry about services and at the time we
were trying to recruit them into the study.’
In addition to these organisational changes, practi-
tioners were perceived to be ‘choosing’ carers who were
likely to benefit from the intervention (see discussion re
gatekeeper role), as the PI explained,
‘They were almost giving them out to who they thought
would benefit. In some, what they were making a
decision about who would get most benefit and which
it would be disruptive to so we had to keep meeting
with them saying that wasn’t, you know, it wasn’t about
choosing who to distribute to. We tried to explain that
everyone had to have an equal chance of making the
decision themselves. That was really, really difficult and
I’m still not convinced that it came across.’
A key effect that appeared to mediate this intercontex-
tual dependence was the potential for the individualsTable 6 Support for proposition 2 - complex
interventions evolve and change
Findings in support of proposition Evidence source
Trial
1
Trial
2
Trial
3
Trial
4
Trial
5
Trial
6
Trial
7
1. Standardising complex
interventions is challenging, because
interventions may frequently be
inseparable from contexts and
contexts themselves are rarely static.
✓✓ ✓✓ ✓✓ ✓✓ ✓✓ ✓✓
2. Researchers generally have a
theory of how the intervention and
trial should work but this is not always
made explicit. Theories of how an
intervention actually should or does
work can also change as contextual
information becomes more apparent.
✓✓ ✓✓ ✓ ✓✓ ✓✓ ✓✓ ✓✓
3. Relationships between people
involved in complex intervention
trials evolve and change thereby
changing the intervention.
✓ ✓ ✓ ✓
4. Complex intervention trials have
a knock-on effect on the practice
context, which may then lead to
further evolution and change in the
intervention.
✓✓ ✓ ✓✓ ✓ ✓✓
✓= some evidence (one instance); ✓✓= strong evidence (more than one
instance); no check/tick = no specific evidence.and organisation involved to operate as a self-regulating
system. For example, in the sleep and exercise trials, as
seen in the quotes below, participants in the control arm
were perceived to have been motivated to participate in
their own interventions. Indeed, trial data showed that
patients in the control group engaged in more hours of
exercise than the intervention group: -
‘The control group got better all by itself . . . was it
the Hawthorne effect? Did they start looking at
interventions to rectify the problem because they
knew they had to wait six months [for a staggered
intervention?]
‘The control people wanted to be, I thought they
would be relieved to be in the control group but
weren’t, so they were always very disappointed.’
Another important aspect of the ‘problem context’ was
shown in the sleep trial, where it was clear that partici-
pants taking part in the trial were, by nature, different
from those who might seek the intervention in a real life
setting, and that this inevitably influenced engagement
with the intervention:
‘People who come to the normal clinic have
approached a health professional saying “I need help”.
I had approached these families, and said “I recognise
you have a problem, would you like to take part in
this trial and come to this clinic?”. So it was on a very
different footing, they hadn’t asked for the help, they
were offered it . . . I think that may have tipped the
balance for some of them.’
Support for proposition 2 - that complex interventions
tend to evolve over time - was identified across all trials
and stemmed from four sub-domains (see Table 6): first,
the frequent inability to meaningfully separate the inter-
vention itself from the changing contexts within which it
was embedded; second, the changing understanding of the
researchers regarding the perceived cause underlying the
problem and thus intervention; third, changes in the rela-
tionships between and among practitioners and research-
ers upon which the intervention may be dependent; and
fourth, that the intervention and trial can have a knock-on
effect on the practice setting (organisational and problem
contexts) which then influence or constrain the interven-
tion being delivered. Strongest cross-trial support was
found for the first two sub-domains, while least frequent
and evident support existed for the third.
These findings suggested that the distinction between
context and intervention may be more conceptually than
practically meaningful. Although documentation defined
the intervention in terms of a distinct set of events, PIs
frequently talked in terms of processes and mechanisms in
a more expansive and inclusive manner rather than
regarding the intervention as a distinct ‘thing’. Indeed, this
highlighted a potentially important distinction between
documentation and discussion. Documentation tended to
Table 7 Support for proposition 3 - the assumptions of
the RCT method are less relevant to trials of complex
interventions
Findings in support of proposition Evidence source
Trial
1
Trial
2
Trial
3
Trial
4
Trial
5
Trial
6
Trial
7
1. The contextual factors identified
create a number of challenges for RCTs
of complex interventions. Tensions
exist between the methodological
ideals of the RCT method and the
reality of evaluating complex
interventions within a real life setting
and producing useful and meaningful
evidence about that intervention.
✓✓ ✓✓ ✓✓ ✓✓ ✓✓ ✓✓
2. Particular challenges exist in relation
to achieving objectivity and
standardisation. Personal contexts
challenge the concepts of objectivity
and equipoise, and all aspects of the
reality of clinical practice can interfere
with attempts to standardise
interventions and protocols.
✓✓ ✓ ✓ ✓✓ ✓
3. The greater the dependence of the
intervention and control arms of a trial
on the SAME organisational and
personal contexts the greater the
likelihood that the distinction between
the intervention and control will
become blurred - contextual
commonality.
✓✓ ✓ ✓✓ ✓ ✓
4. Changes in the organisational
context can differentially impact on
the delivery, and thus potentially on
the effectiveness, of the intervention
and the control.
✓✓ ✓✓
✓= some evidence (one instance); ✓✓= strong evidence (more than one
instance); no check/tick = no specific evidence.
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events and sequences. However, interviews with PIs
revealed a far more nuanced understanding of the inter-
vention and how it should work. Initially, much of this
remained tacit but emerged throughout the interview
process after reflection. It appeared, however, that this
more sophisticated understanding had not emerged simply
as a result of the medium of the interview, but had existed
during the trial, often developed as a result of operational-
izing the trial protocol. As one researcher said,
‘If you’re being strict about the way you do the trial
then I agree, you shouldn’t really change anything, but
I think it’s very hard if you get to the middle of
something like a three-year trial and you can see that
things aren’t working, it’s . . . I mean I felt like should
I be getting in touch with the funding body and
saying look this isn’t working, we ought to be doing
something different, and everybody was saying “oh no,
you can’t do that, they’ll take all our money away”.’
Often, interventions themselves differed to those that
had originally been planned, or were adapted along the
way to improve compliance. Several interventions were
designed to include a specific number of ‘sessions’ with
a practitioner, but the minimum and maximum number,
nature and duration of sessions actually received was ex-
tremely variable and this variability had not been pre-
specified. Sometimes, interventions had been conceptua-
lised or operationalised differently at the beginning. In
one case, an independent assessor of tape recorded cog-
nitive behavioural therapy (CBT) intervention sessions
had commented that ‘what was delivered wasn’t pre-
cisely what he thought should have been delivered, it
was sort of acceptable for one model but not acceptable
for a model that he proposes’. In another, the PI wrote
in a six-month report; ‘the distinction between the two
interventions provided in this study may not be as pro-
nounced as originally intended’.
Support for proposition 3 - that some of the assump-
tions underpinning RCTs may be compromised for trials
of complex interventions - was found to depend on four
sub-domains, each of which had varying support across
the trials (see Table 7). These sub-domains included: the
impact of contextual factors on the RCT; the difficulty
of standardisation; the potential inability to meaningfully
separate intervention from control given some context-
ual commonality upon which they may be dependent;
and the potential for changes in organisational contexts
to differentially impact on the intervention and control
groups. Given the earlier indications of the importance
of context, it was unsurprising that the strongest and
most consistent support related to sub-domain one.
However, support for the other domains was evident in
a spectrum of trials. PIs acknowledged the principles
underpinning RCTs, but demonstrated that in reality,these were highly challenging to maintain. Assumptions
were often made about the mechanisms between cause
and effect, and strict adherence to the protocol without
attention to context meant that important details were
often obscured. As one insider on a cluster trial
commented,
‘We were targeting the intervention at one group and
gathering the information from another, I think that
was laying us open to finding nothing, which was
what happened . . . I think that was fairly evident
actually, even at the beginning, but I don’t think
enough people noticed it, put it that way. And they
were so tied up with the idea . . . that they didn’t
actually stop and think are we actually going to see
any change here. And it was patently obvious that we
weren’t from the word go.’
Although least frequent support was identified in rela-
tion to the differential impact of changes in context on
the intervention and control groups, in practice this may
be extremely important and previously unacknowledged.
For example, the degree of practitioner confidence, skill,
Table 8 Key dimensions of complex interventions
1. Principles/purpose/function - what the intervention is designed to do
2. Target of intervention - is this direct or indirect (that is, does
intervention depend on different people/steps to have an impact
on target)
3. Structure and architecture - what elements are included and how
are they put together (that is, components, steps, order)
4. Theory behind the links between target, structure and purpose
(that is, links between 1, 2 and 3)
5. Crucial/central components or defining features (take note, may be
an interaction or encompassing element of the bundled intervention)
6. Level of flexibility/tailoring and at what level (that is, tailored
to individual, to practitioner, to clinical area)
7. Degree of active participation required from patients/target group
8. Factors that may encourage participation, compliance or uptake
from patient/target group
9. Dependence on healthcare professionals - level of input required
and at what stages/steps of intervention
10.Number of healthcare professionals required - discrepancies
between them
11.Essential characteristics/attributes of healthcare professionals
necessary for intervention - skills, knowledge, time, resources,
affinity or preference for intervention
12.Location(s) - single, multiple, mixed, home/hospital/primary
care, across boundaries
13.Time span - overall timing of intervention, including relationship
between recruitment and intervention start/finish, relationship
between intervention and timing of illness or critical event,
relationship between intervention and outcome measurement
14.Timing of intervention components within structure/architecture of
intervention - that is, duration, intervals between, number of sessions
15.Organisational pre-requisites - practitioners, settings, organisational
support, organisational structure.
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central to the delivery of complex interventions and to
the differentiation between control and experimental
interventions, but this is rarely studied or reported. In-
deed, PIs revealed that their RCTs had not always pro-
duced useful information that would actually assist in
the implementation of similar interventions:
‘I think this study would have benefited from having a
more qualitative element in it as well . . . at the end of
the day, I would want a bit more detail about what
factors would make participants engage in the
intervention . . . there’s a lot more to it, I think, than
this particular methodology.
‘I feel there is a need for qualitative data to colour in a
lot of the problems, I mean it’s good to evaluate, but it’s
also good to use these kinds of experiments as a way of
finding out the problems that are going to be involved
in implementing an intervention into real life.’
However, it was clear that even when interventions
had not ‘worked’ and RCTs had not delivered the evi-
dence that researchers had hoped for or expected, the
trial had often, over time, acted as a catalyst to changes
in attitude or organisation of care, which was perceived
as a good thing:
‘It’s changed a lot for the better, I mean it’s still by no
means everybody . . . but certainly a much higher
proportion [are now engaging in the intervention].
Feedback from the nurses is that a lot of them are
using it in practice now. It’s changed the way they see
clients.’
Discussion
Summary of findings
We identified a set of characteristics and dimensions
that may help describe complex interventions more fully
(see Table 8). These dimensions exist and evolve in dy-
namic contexts that cannot merely be viewed as the
inert backdrop for the delivery of the intervention, but
are part of the intervention. Pawson et al. (2005) de-
scribe interventions as ‘leaky’ [22], although they are
based on particular theories and given particular titles,
they are then ‘delivered in a mutating fashion shaped by
refinement, reinvention and adaptation to local circum-
stances’ (p23). This ‘evolution’ may have unintended
consequences such as blurring the distinction between
intervention and control, and certain aspects of the
intervention ‘slipping’. What matters is less that this
occurs (indeed, it can be anticipated for many interven-
tions simply because different people will deliver it) but
that it is known, understood and reported.
We identified empirical evidence to support the im-
pact of personal, problem, organisation and trial con-
texts on the running of all trials studied. Importantly,
particular elements of these trials appeared to becomeessential to the effectiveness of the interventions but
sometimes changed over time, resulting in varying levels
of challenge to the standardisation, control and objectiv-
ity of the trial. The nature of the complexity within and
around interventions was often embodied in health prac-
titioners’ experience and investigators’ tacit knowledge
about the intervention and its implementation. There is
a need to explore ways of making these explicit and pub-
lic. This would help us understand what really contribu-
ted to trial outcomes and is essential for replication and
use in clinical settings, and for further research [39].
Discussion of findings in relation to the literature
Taxonomies of complexity
Our findings suggest that a taxonomy of complexity may
be useful in reflecting different types of contextual influ-
ences in trials of complex interventions. Some work in
this area has already begun, led primarily by behavioural
scientists/health psychologists, categorising behaviour
change interventions, techniques and theories [40]. The
taxonomy developed by Schulz et al. organises the
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egories: 1) treatment delivery characteristics (including
mode of delivery, materials, location, schedule, scripting,
sensitivity to participant characteristics, interventionist
characteristics, adaptability and treatment implementa-
tion) and 2) intervention content (treatment content
strategies and mechanisms of action) [25].
Intervention taxonomies have a number of benefits,
including the highlighting of elements of an intervention
that need to be addressed prior to study implementation
through pilot work; the recording of intervention details
so that analyses can take these into account; and the
overall benefits to intervention science [25]. The clear
role of what we call contextual factors suggests that
trials of some types of complex interventions may be
particularly vulnerable to threats to internal validity such
as standardisation and intervention fidelity, and that this
should be studied explicitly during the trial. Given the
varying dependence of the intervention on the personal,
problem and organisational contexts within which it is
delivered, it is also likely that complex interventions will
vary in their generalisability to settings that differ in
some degree to that of the original trial [41]. The effect-
iveness of some interventions may be context resilient
(that is, be retained across diverse settings); while others
may be highly context sensitive (that is, effectiveness
may be lost quickly when applied to different settings or
even patient groups). Indeed, recent studies have
endorsed one of our own findings, that the characteris-
tics and experiences of the population taking part in a
trial may differ in important ways from the ‘real’ popula-
tion who would normally take up the intervention [41].
Others have found that policy changes can dramatically
change the recruitment context in which trials take
place, for example, the introduction of a national smok-
ing ban in public places during a trial of a smoking ces-
sation intervention [42]. Our case study adds support to
the findings of others suggesting that such taxonomies
can be used across multiple trials to identify critical
components of interventions and their contexts, and to
assess their actual and potential relationship to out-
comes [25,43].
Widening theoretical eclecticism for the development of
complex interventions
Both the 2000 and 2008 versions of the MRC framework
highlight the importance of a theoretical basis for the
intervention [1,7]. Indeed, given that standardisation of
the manifest operational characteristics of the interven-
tion may prove impossible, the best definition of the
intervention may in fact be the theory that underpins it.
Since the majority of complex interventions have a be-
havioural component, theory is often required from the
behavioural and social sciences, particularly healthpsychology. However, given the importance of organisa-
tional contexts as evidenced in our study, it is likely that
theory from other disciplines may be appropriate, in par-
ticular organisational and management theories. Re-
search in the area of social interventions, health
promotion and public health that rely on ‘theories of
change’ [44] already suggests that when complex behav-
ioural interventions are created, judgments are being
made about the ways in which organisations and con-
texts interact. Indeed, the first task in such theory of
change approaches is often to interview the intervention
developers to make the assumptions and theory fully ex-
plicit. Alternatives to such theory of change approaches
are increasingly appearing, including RE-AIM [45], inter-
vention mapping [46] and logic modelling [47].
Attitudes and behaviour of practitioners or researchers
Our study showed that practitioners’ roles in research
and in their organisation largely shaped the process of
the trial and the context within which it operated. First,
recruitment and delivery of the intervention depended
on their enthusiasm for the intervention and evaluation.
A 2006 systematic review of barriers to participation in
cancer trials found that clinicians’ concerns about study
design and intervention risks and benefits undermined
their support for trials [48]. Practitioners sometimes
consider complex interventions and trials to be the same
thing; therefore, if they do not wish to be involved in
providing the intervention, they also reject the trial
[49,50]. Clinicians may also reject a complex interven-
tion because of concerns of how it will fit in with their
normal practice. All this means that clinicians may em-
ploy a gate-keeping role. However, while the literature
has explored barriers to recruitment [48], it has not
examined in any detail the problem of gate-keeping by
clinicians. Many attempts to improve recruitment to
RCTs have tended to concentrate on ways of improving
the information and support given to potential partici-
pants rather than to potential gate-keepers [51,52], and
this needs to be addressed.
Once on board, practitioners’ enthusiasm for a trial
cannot be assumed to be constant. Research has found
that members of staff need to be involved from the be-
ginning, asked for their opinions, and constantly
updated on trial progress to maintain their enthusiasm
[53]. A systematic review of factors limiting clinician
participation in trials found that barriers to clinician par-
ticipation included time constraints, lack of staff, con-
cern about the impact on doctor-patient relationships,
concern for patients, loss of professional autonomy, dif-
ficulty with consent procedures and an insufficiently
interesting question [54]. A later review confirmed the
importance of a clinically relevant research question and
good communication [55].
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may make the reality of randomisation particularly chal-
lenging [56] and it is important that trialists provide evi-
dence of randomisation integrity. As our findings revealed,
practitioners often have ways of compensating control
patients by giving them more information, which may en-
courage contamination between the randomised groups
[57]. Indeed, Schulz (1995) argues that ‘RCTs are anath-
ema to the human spirit’ and that once practitioners ‘are
engaged in a trial they may find it too difficult to maintain
a dispassionate stance’ [58]. We found that practitioners
and researchers experienced emotional, practical and
philosophical difficulties with adopting the objective per-
spective required by quantitative research. Other studies
have confirmed such conflicts, showing, for example, that
blinding can be associated with poorer recruitment [59]
and that researchers and practitioners experience a num-
ber of challenges to maintaining fidelity in RCTs, particu-
larly related to the balance they need to strike between
research and clinical roles [60].
Reporting and reflexivity
As mentioned earlier, for complex intervention trials to
have an impact on practice they need to provide decision
makers - whether at policy or practice level - with suffi-
cient information on the operation and findings of the
trial that they can assess validity, reliability, benefit and
replicability. Our findings suggest that current reporting
standards such as CONSORT [61] are likely to be insuf-
ficient to inform clinical and policy judgments. Two
issues are important here. First, relevant variables that
might aid judgments about internal and external validity
need to be reported; and second, sufficient depth and
detail with regard to each of those variables is required.
While taxonomies of differing complex interventions
may eventually generate new reporting standards, it is
likely that the very complexity and idiosyncratic nature of
such trials and settings means that relying on reporting
standards alone is insufficient. Threats to internal and ex-
ternal validity are likely to emerge that have never and
could never have been foreseen and are not listed on
reporting standards. Our data suggest that researchers, at
least in the past, have tended to be reticent in articulating
and reporting the influence of contextual factors on the
delivery of interventions within the conduct of their trials,
because the RCT has largely been viewed as a controlled
and standardisable method, which is acontextual.
Between 2004 and 2010, developments and debates
have led to much more open acknowledgement of the
challenges of (and some solutions for) conducting RCTs
of complex interventions [7,8,62]. A cultural change in
reporting is also required; one which regards honest and
open reporting as a symbol and requisite of quality in
any critical appraisal. Lack of reporting such issues fortrials of complex interventions should rightly be
regarded as a sign of poor quality, inadequate monitor-
ing and data collection. Managing methodological qual-
ity across highly diverse settings has always been a
central challenge for qualitative research [63]. We would,
therefore, suggest that the concept of ‘reflexivity’ devel-
oped in relation to qualitative research, could usefully be
applied to all types of research [64-66]. Reflexivity
requires the researcher to explicitly acknowledge how
researchers’ motivations, personal experiences and inside
knowledge of healthcare can affect the way in which
they approach the conduct of their research. Finlay and
Gough (2003) have set out five variants of reflexivity that
could serve as useful guidelines to explore in the con-
duct and reporting of any research [67]:
‘Five variants of reflexivity’ Finlay and Gough (2003).
1) Reflexivity as introspection - reflection on own
experiences and how they relate to the research
being conducted. The researcher’s own experiences
may influence the research subject, methods chosen,
and interpretation of results.
2) Reflexivity as intersubjective reflection - researchers
explore the mutual meanings involved within the
research relationship. For example, our finding show
that researchers were affected by the experiences of
research participants, and sometimes this caused
them discomfort, particularly when their participants
were going through difficult periods of illness.
3) Reflexivity as mutual collaboration - research as a
co-constituted account. Our findings illustrate how
researchers developed relationships with participants
and clinical staff, which affected the nature of data
collected and the commitment of parties to the trial.
4) Reflexivity as social critique - recognises the power
imbalance between researcher, practitioner, and
participant. Our findings illustrated that researchers
and practitioners do have preconceived ideas about
whether or not the intervention would suit certain
types of people. We also noted that gate-keeping by
practitioners did exist. Both of which suggest a
power imbalance between the actors (researchers,
participants and practitioners) involved in research.
5) Reflexivity as ironic deconstruction - recognising
ambiguities and multiplicities of meaning. Our
researchers’ accounts show that most did not think
the results of the trial portrayed the whole picture,
and that there were a number of ambiguities and
uncertainties about how interventions had worked
or not worked, which remained unspoken.
The application of the concept of ‘reflexivity’ to quanti-
tative research would promote transparency around the
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more realistic accounts of the trial context. This would en-
able researchers to learn from others’ mistakes, anticipate
potential sources of bias, and barriers to recruitment.
However, we also note that the tools that encourage re-
flexivity may, in some circumstances, become part of the
intervention rather than a component of the evaluation.
For example, one study concluded that conducting a
process evaluation alongside a RCT effectively acted as a
formative mechanism of feedback to practitioners, encour-
aging them to reflect on the process of implementing the
intervention, and thus subtlety change the intervention
[68]. However, this approach may be extremely important
to understanding the complexity, flux and contextual vari-
ation that inevitably occurs in real life situations [62].
Strengths and limitations
To our knowledge, this is the first multiple case study of a
spectrum of trials of complex interventions. The two-
phase design enabled a detailed analysis of insiders’ per-
spectives of a single trial to inform further exploration of
the context of several different trials. This provided an op-
portunity to use the advantages of the case study approach,
through exploration, explanation and theory development.
However, the explanatory phase of the study relied
heavily on PIs’ perspectives and would have been
strengthened by interviews with other stakeholders, in-
cluding participants. Additionally, some of the trials
sampled were small and were conducted by relatively
novice researchers, and most took place in a single site.
Although this could potentially explain or limit the gen-
eralisability of our findings, 1999 and 2006 analyses of
individual trials have revealed very similar issues, illus-
trating the importance of this work [69,70].
The way forward?
Trials that take a more pragmatic design approach may
provide a solution to the problem of evaluating complex
interventions [69,71]. Instead of trying to test the effi-
cacy of an intervention under ideal, experimental condi-
tions, ‘pragmatic trials are designed to find out about
how effective a treatment actually is in routine, everyday
practice’ [66]. Because of this, results are seen to be
more generalisable. However, there may be a trade-off
between internal validity (exemplified by the explanatory
trial) and external validity (exemplified by the pragmatic
trial) and here internal validity could be compromised to
ensure generalisability [72], although this remains to be
shown empirically. Furthermore, it cannot always be
assumed that pragmatic trials really do reflect the real
world. Our findings suggest that the very fact that a
complex intervention trial is being conducted changes
everyday practice making the trial context different from
the real world.Routinely conducting process evaluations alongside
pragmatic trials may help. Conceptual models that pro-
vide interpretive frameworks for evaluations have been
developed such as the Normalization Process Theory
[73]. This framework asks what people do to make the
complex intervention workable and to integrate it in
practice. However, collecting process data can raise add-
itional difficulties [27,68,70]. Researchers, for example,
may perceive that an intervention is not working well
and then be faced with the dilemma of whether to act
on it before the end of the trial [74].
As suggested by the 2008 MRC framework, there are a
variety of ways in which trials can be modified to take ac-
count of complexity and contextual variation in healthcare
practice, including alternative designs such as cluster,
stepped wedge or preference designs. Lessons learned
from conducting community and public health trials could
be usefully applied to trials that take place in more acute
settings, where aspects of context are less often consid-
ered. Articulating the contextual dimensions of complex
interventions using a taxonomy, and incorporating
process evaluation (and publishing their protocols), moni-
toring and reporting of particular threats to validity
throughout the trial would improve transparency. Consid-
eration of how the CONSORT extension for complex
intervention trials, or the CONSORT statement itself,
could be modified to support better reporting of context-
ual information is also warranted. Finally, it must be
recognised that the randomised controlled trial is not ap-
propriate or meaningful for all research questions, and
there are many other evaluation approaches that are also
important for health improvement [62].Conclusion
Our findings add support to the growing interest in the
influence of context on trials of complex interventions.
Rather than considering context as of background inter-
est, this study illustrates that contextual factors shape or
co-construct complex interventions and, therefore, can-
not be considered separate from those interventions.
Context includes the influence of individuals, teams, or-
ganisational structures and cultures, resources, leader-
ship styles and relationships [75]. This suggests that
evaluations need to incorporate multiple methods, mul-
tiple sources and multiple perspectives if they are to re-
flect the context of practice adequately.Abbreviations
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